|
Use of Biomarkers in Oil Spill Risk Assessment in the Marine Environment
|
ABSTRACT
Numerous molecular, cellular, and physiological biomarkers have been used to assess the responses of marine animals to petroleum compounds. To be used in ecological risk assessment after an oil spill, a biomarker response needs to be linked to petroleum exposure and not strongly influenced by internal and external confounding factors. Biomarker responses to petroleum PAH, dominated by alklated two- and three-ringed aromatics, can be quite different than responses to pyrogenic ...
Related newspaper, magazine, and journal articles from HighBeam Research
|
Biomarkers move beyond discharges to measure mill effluent effects
Pulp & Paper
; With their use growing in the pulp and paper industry, biomarkers can function as "early warning" effluent monitors THE PULP AND PAPER INDUSTRY HAS A LARGE variety of production and product technologies, which are in a state of continual change to meet both market and environmental requirements. At
|
|
Biomarkers in cancer screening: A public health perspective
The Journal of Nutrition
; Biomarkers in Cancer Screening: A Public Health Perspective1 ABSTRACT The last three decades have witnessed a rapid advancement and diffusion of technology in health services. Technological innovations have given health service providers the means to diagnose and treat an increasing number of
|
|
Biomarkers of Disease: An Evidence-based Approach
Clinical Chemistry
; Biomarkers of Disease: An Evidence-based Approach. Andrew K. Trull, Laurence M. Demers, David W. Holt, Atholl Johnston, J. Michael Tredger, and Christopher P. Price, eds. Cambridge: Cambridge University Press, 2002, 516 pp., $110.00, hardcover. ISBN 0-521-81102-3. This book, published last year, is
|
|
|
Biomarkers of nutritional exposure and nutritional status: An overview
The Journal of Nutrition
; Biomarkers of Nutritional Exposure and Nutritional Status: An Overview1,2 KEY WORDS: * biomarkers * diet assessment * epidemiology * nutrition * methodology A nutritional biomarker can be any biological specimen that is an indicator of nutritional status with respect to intake or metabolism of
|
|
Biomarkers Come of Age
Pharmaceutical Executive
; In the past five years, biomarkers have become an essential part of pharmaceutical R&D. Seven industry experts explain how it happened-and what comes next. In a few years' time, or so the conventional wisdom goes, personalized medicine will become a reality, and many (or even most) new drugs
|
|
Biomarkers of Disease: An Evidence-Based Approach
Archives of Pathology & Laboratory Medicine
; Edited by Andrew K. Trull, Laurence M. Demers, David W Holt, Atholl Johnston, J. Michael Tredger, and Christopher P Price, 494 pp, with illus, Cambridge, United Kingdom, Cambridge University Press, 2002. The back cover of Biomarkers of Disease: An Evidence-Based Approach sets a lofty goal: "This
|
|
|
Methodologic and statistical considerations regarding use of biomarkers of nutritional exposure in epidemiology
The Journal of Nutrition
; Methodologic and Statistical Considerations Regarding Use of Biomarkers of Nutritional Exposure in Epidemiology1 ABSTRACT In nutritional epidemiology, accurate quantification of nutritional exposure is critical. Even moderate flaws in measurement can lead to sizeable distortions in estimations of
|
|
|
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Clinical Chemistry
; Background: Evaluation of patients who present to the hospital with a complaint of chest pain or other signs or symptoms suggestive of acute coronary syndrome (ACS) is time-consuming, expensive, and problematic. Recent investigations have indicated that increases in biomarkers upstream from
|
|
|
A Research Agenda for Biomarkers as Indicators of Cancer Risk Reduction Following Dietary Manipulation1,2
The Journal of Nutrition
; Background The U.S. government has convened several public meetings and workshops to explore the role of biomarkers as tools for cancer detection and for assessing cancer risk. In 1999 NIH and FDA held a workshop entitled Bioiuarkers and Surrogate Endpoints: Clinical Research and Applications (1).
|
|
BIOMARKERS FOR DISEASE MODIFICATION TRIALS - THE INNOVATIVE MEDICINES INITIATIVE AND ADDNEUROMED
The Journal of Nutrition, Health & Aging
; In a previous issue of the Journal we reviewed the pressing and urgent need for biomarkers in Alzheimer's Disease (AD) ( 1 ). This need has become no less urgent or pressing and indeed arguably becomes more so as increasing numbers of compounds pass the phase II barrier and move to phase HI trials.
|